Core Viewpoint - Harrow, a leading provider of ophthalmic disease management solutions in North America, will report its third-quarter financial results on November 10, 2025, and host a conference call on November 11, 2025, to discuss these results and provide a business update [1]. Company Overview - Harrow, Inc. (Nasdaq: HROW) specializes in ophthalmic disease management, offering a comprehensive portfolio of products for conditions affecting the eye, including dry eye disease, age-related macular degeneration, cataracts, refractive errors, glaucoma, and other ocular surface and retina diseases [3]. - The company is committed to delivering safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes [3]. Conference Call Information - The conference call will be accessible via a live webcast on Harrow's "Investors" page, with a replay available for one year [2]. - Participants can join the call by registering in advance to receive a unique dial-in number and PIN [2].